Bonita David P
Insider CIK 1572451 · AMBI Director, 10% owner · SIBN Director · AFIB Director, 10% owner · LOXO Director, 10% owner · TCDA Director, 10% owner · VRAY Director, 10% owner · IMRA Director, 10% owner · PRLD Director, 10% owner · RPTX Director · IKNA Director · THRD Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMA ImageneBio, Inc. | A Award deriv | 2026-06-16 | 2026-06-18 | 15,600 | — | $0 | 15,600 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 38,000 | — | $0 | 38,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,126,126 | $4.44 | $5.00M | 1,126,126 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,689,189 | $4.44 | $7.50M | 11,808,945 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy deriv | 2026-04-14 | 2026-04-16 | 336,603 | — | $0 | 336,603 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy deriv | 2026-04-14 | 2026-04-16 | 384,689 | — | $0 | 384,689 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other deriv | 2025-08-11 | 2025-08-14 | 43,584 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | J Other | 2025-08-11 | 2025-08-14 | 5,779,071 | — | $0 | 0 | SEC↗ |
| IMA ImageneBio, Inc. | M Exercise deriv | 2025-07-25 | 2025-07-30 | 17,520 | — | $0 | 0 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy | 2025-07-25 | 2025-07-30 | 83,611 | $29.90 | $2.50M | 287,885 | SEC↗ |
| IMA ImageneBio, Inc. | M Exercise | 2025-07-25 | 2025-07-30 | 379 | — | $0 | 379 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-06-12 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2024-06-17 | 2024-06-20 | 27,200 | — | $0 | 27,200 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,500 | — | $0 | 23,500 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 17,520 | — | $0 | 17,520 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-08-04 | 2023-09-14 | 353,192 | — | $0 | 353,192 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-08-04 | 2023-09-21 | 353,192 | — | $0 | 353,192 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award | 2023-08-04 | 2023-09-14 | 153,121 | — | $0 | 2,251,218 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award | 2023-08-04 | 2023-09-21 | 153,121 | — | $0 | 5,582,144 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 23,500 | — | $0 | 23,500 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 20,822 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-06-09 | 2023-06-13 | 17,520 | — | $0 | 17,520 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 27,200 | — | $0 | 27,200 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-22 | 2023-05-24 | 869,565 | $5.75 | $5.00M | 10,119,756 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2022-11-25 | 2022-11-25 | 3,629,226 | $0.22 | $798.4K | 0 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2022-11-23 | 2022-11-25 | 5,617,300 | $0.21 | $1.18M | 3,629,226 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2022-11-22 | 2022-11-25 | 1,034,421 | $0.22 | $227.6K | 9,246,526 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-21 | 8,593,750 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-21 | 1,342,065 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-21 | 2,441,407 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion | 2022-09-19 | 2022-09-21 | 5,479,071 | — | $0 | 5,479,071 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-09-19 | 2022-09-21 | 300,000 | $17.00 | $5.10M | 5,779,071 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-24 | 2022-06-24 | 96,035 | $5.37 | $515.7K | 2,098,097 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-24 | 2022-06-24 | 65,965 | $4.37 | $288.3K | 2,002,062 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-23 | 2022-06-24 | 23,419 | $3.71 | $86.9K | 1,936,097 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-22 | 2022-06-24 | 66,806 | $3.55 | $237.2K | 1,912,678 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 34,300 | — | $0 | 34,300 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 12,422 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 27,207 | — | $0 | 27,207 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 13,419 | — | $0 | 13,419 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 8,500 | — | $0 | 8,500 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2022-05-13 | 2022-05-16 | 49,000 | — | $0 | 49,000 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2021-12-21 | 2021-12-23 | 13,419 | — | $0 | 13,419 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-11-15 | 2021-11-17 | 666,667 | — | $0 | 666,667 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2021-11-15 | 2021-11-17 | 666,667 | $6.00 | $4.00M | 10,280,947 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-08 | 861 | $33.93 | $29.2K | 3,177,041 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-08 | 26 | $33.93 | $882 | 96,190 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-03 | 2021-09-08 | 6,985 | $34.00 | $237.5K | 3,177,902 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-03 | 2021-09-08 | 212 | $34.00 | $7.2K | 96,216 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-02 | 2021-09-02 | 15,941 | $34.24 | $545.8K | 3,184,887 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-02 | 2021-09-02 | 483 | $34.24 | $16.5K | 96,428 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-02 | 382 | $33.98 | $13.0K | 96,911 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-02 | 12,586 | $33.98 | $427.7K | 3,200,828 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-31 | 2021-09-02 | 249 | $33.94 | $8.5K | 97,293 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-31 | 2021-09-02 | 8,223 | $33.94 | $279.1K | 3,213,414 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-30 | 2021-08-30 | 197 | $33.92 | $6.7K | 97,542 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-30 | 2021-08-30 | 6,500 | $33.92 | $220.5K | 3,221,637 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-27 | 2021-08-30 | 6,884 | $33.94 | $233.6K | 3,228,137 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-27 | 2021-08-30 | 209 | $33.94 | $7.1K | 97,739 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-26 | 2021-08-30 | 4,157 | $34.52 | $143.5K | 3,235,021 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-26 | 2021-08-30 | 126 | $34.52 | $4.3K | 97,948 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-25 | 2021-08-25 | 208 | $34.34 | $7.1K | 98,074 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-25 | 2021-08-25 | 6,874 | $34.34 | $236.1K | 3,239,178 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-24 | 2021-08-25 | 119 | $34.07 | $4.1K | 98,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-24 | 2021-08-25 | 3,920 | $34.07 | $133.6K | 3,246,052 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-23 | 2021-08-25 | 209 | $34.06 | $7.1K | 98,401 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-23 | 2021-08-25 | 6,885 | $34.06 | $234.5K | 3,249,972 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-19 | 2,852 | $33.99 | $96.9K | 3,256,857 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-19 | 78 | $33.99 | $2.7K | 98,610 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-25 | 78 | $33.99 | $2.7K | 98,610 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-25 | 2,852 | $33.99 | $96.9K | 3,256,857 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-19 | 512 | $34.12 | $17.5K | 98,688 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-19 | 16,886 | $34.12 | $576.2K | 3,259,439 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-25 | 512 | $34.12 | $17.5K | 98,688 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-25 | 16,886 | $34.12 | $576.2K | 3,259,439 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 357,143 | $14.00 | $5.00M | 1,677,361 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 714,285 | $14.00 | $10.00M | 4,872,025 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2021-07-16 | 2021-07-16 | 1,666,666 | $6.00 | $10.00M | 1,666,666 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2021-07-16 | 2021-07-23 | 1,666,666 | $6.00 | $10.00M | 4,199,068 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2021-06-29 | 2021-06-30 | 7,728 | — | $0 | 7,728 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-06-18 | 2021-06-22 | 23,344 | — | $0 | 23,344 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 4,022 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 57,235 | — | $0 | 57,235 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2021-06-10 | 2021-06-11 | 16,403 | — | $0 | 27,584 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2021-05-13 | 2021-05-14 | 21,000 | — | $0 | 21,000 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 68,978 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 130,924 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 328,907 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 920,484 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 806,752 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 2,257,785 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 680,766 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 1,905,201 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 551,259 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 2,411,260 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 983,054 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 653,277 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 2,034,708 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 266,337 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 157,288 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-14 | 42,614 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 130,924 | — | $0 | 130,924 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 5,083,470 | — | $0 | 5,083,470 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 1,816,425 | — | $0 | 1,816,425 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 68,978 | — | $0 | 68,978 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 48,400 | $16.00 | $774.4K | 117,378 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 375,000 | $16.00 | $6.00M | 2,191,425 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-14 | 375,000 | $16.00 | $6.00M | 1,845,872 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-14 | 5,429,023 | — | $0 | 5,429,023 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-14 | 48,400 | $16.00 | $774.4K | 91,014 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-14 | 157,288 | — | $0 | 157,288 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-14 | 42,614 | — | $0 | 42,614 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-14 | 1,470,872 | — | $0 | 1,470,872 | SEC↗ |
| PRLD | P Buy deriv | 2021-01-11 | 2021-01-12 | 41,700 | $60.00 | $2.50M | 5,596,886 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-01 | 1,430,103 | $1.40 | $2.00M | 1,430,103 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-01 | 8,938,148 | $1.40 | $12.51M | 8,938,148 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-14 | 1,430,103 | $1.40 | $2.00M | 1,430,103 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-14 | 8,938,148 | $1.40 | $12.51M | 8,938,148 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 619,850 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 5,555,186 | — | $0 | 5,555,186 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 413,234 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 2,945,458 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 4,418,186 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 2,196,494 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 3,294,743 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-30 | 8,332,779 | — | $0 | 9,250,191 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-25 | 2020-09-30 | 526,300 | $19.00 | $10.00M | 526,300 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-25 | 2020-09-30 | 710,500 | $19.00 | $13.50M | 917,412 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2020-09-24 | 2020-09-30 | 46,688 | — | $0 | 46,688 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2020-08-21 | 2020-09-30 | 1,033,084 | — | $0 | 1,033,084 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 378,733 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,202,117 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 389,116 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 899,985 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 647,582 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 673,123 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 872,302 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 373,500 | $18.00 | $6.72M | 373,500 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,278,718 | — | $0 | 1,320,218 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 3,784,240 | — | $0 | 4,157,740 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 41,500 | $18.00 | $747.0K | 41,500 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2020-08-05 | 2020-08-07 | 12,454 | — | $0 | 12,454 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2020-08-05 | 2020-08-07 | 2,222 | — | $0 | 2,222 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 2,601,325 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 675,000 | $20.00 | $13.50M | 3,276,325 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 2,601,325 | — | $0 | 2,601,325 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 99,200 | $20.00 | $1.98M | 99,200 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 22,967 | — | $0 | 22,967 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2020-06-11 | 2020-06-15 | 5,670 | — | $0 | 11,181 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2020-03-27 | 2020-09-30 | 3,681,822 | — | $0 | 7,363,644 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 10,046,294 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 1,594,902 | — | $0 | 2,532,402 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-12 | 2020-03-16 | 937,500 | $16.00 | $15.00M | 937,500 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-12-11 | 2019-12-12 | 1,500,000 | $40.00 | $60.00M | 9,614,280 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 7,068 | — | $0 | 7,068 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2019-05-31 | 2019-06-04 | 1,879 | — | $0 | 5,511 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-04-03 | 2019-04-05 | 225,000 | $36.00 | $8.10M | 11,114,280 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 572,326 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 179,404 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | P Buy | 2018-10-19 | 2018-10-19 | 200,000 | $15.00 | $3.00M | 985,368 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 179,404 | — | $0 | 785,368 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 605,964 | — | $0 | 605,964 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 4,255,319 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 14,292,958 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 17,117,085 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 6,207,674 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2018-07-02 | 2018-07-02 | 13,147 | — | $0 | 13,147 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,559,716 | — | $0 | 1,559,716 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 4,300,774 | — | $0 | 5,860,490 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2018-07-02 | 2018-07-02 | 3,632 | — | $0 | 3,632 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 368,421 | $19.00 | $7.00M | 10,889,280 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,069,175 | — | $0 | 10,520,859 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 3,591,194 | — | $0 | 9,451,684 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-12-08 | 2017-12-12 | 250,000 | $82.50 | $20.63M | 941,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-22 | 2017-11-27 | 267,000 | $75.00 | $20.02M | 1,191,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 43,300 | $73.48 | $3.18M | 1,638,020 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 8,377 | $76.23 | $638.6K | 1,458,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 71,598 | $75.37 | $5.40M | 1,466,377 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 100,045 | $74.49 | $7.45M | 1,537,975 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 46,680 | $72.46 | $3.38M | 1,681,320 | SEC↗ |
| VRAY ViewRay, Inc. | A Award deriv | 2017-11-15 | 2018-04-25 | 45,633 | — | $0 | 45,633 | SEC↗ |
| VRAY ViewRay, Inc. | A Award | 2017-11-15 | 2018-04-25 | 6,857 | — | $0 | 26,388 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2017-01-18 | 2017-01-20 | 623 | $0.13 | $81 | 3,843 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2017-01-18 | 2017-01-20 | 65,491 | $0.13 | $8.5K | 403,692 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2017-01-18 | 2017-01-20 | 327,459 | $3.00 | $982.4K | 9,369,342 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2017-01-18 | 2017-01-20 | 3,118 | $3.00 | $9.4K | 89,225 | SEC↗ |
| VRAY ViewRay, Inc. | A Award | 2016-09-13 | 2016-09-15 | 19,531 | — | $0 | 19,531 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2016-08-22 | 2016-08-24 | 3,220 | $0.13 | $419 | 3,220 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2016-08-22 | 2016-08-24 | 338,201 | $0.13 | $44.0K | 338,201 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2016-08-22 | 2016-08-24 | 1,127,338 | $2.95 | $3.33M | 9,041,883 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2016-08-22 | 2016-08-24 | 10,736 | $2.95 | $31.7K | 86,107 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2016-08-10 | 2016-08-12 | 447,857 | $26.96 | $12.07M | 1,728,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2016-06-10 | 2016-06-13 | 7,812 | — | $0 | 7,812 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-07-28 | 2015-07-30 | 7,812 | — | $0 | 7,812 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 337,973 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 1,562,499 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 1,562,499 | — | $0 | 1,562,499 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 275,385 | $13.00 | $3.58M | 2,175,857 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 337,973 | — | $0 | 1,900,472 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2014-07-31 | 2014-08-01 | 15,625 | — | $0 | 15,625 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-05-15 | 2014-05-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-23 | 2013-05-24 | 120 | $6.99 | $839 | 14,067 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-23 | 2013-05-24 | 12,380 | $6.99 | $86.5K | 1,476,702 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-22 | 2013-05-24 | 21,100 | $6.86 | $144.7K | 1,464,322 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-22 | 2013-05-24 | 200 | $6.86 | $1.4K | 13,947 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion deriv | 2013-05-21 | 2013-05-22 | 50,256 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion deriv | 2013-05-21 | 2013-05-22 | 5,276,702 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion deriv | 2013-05-21 | 2013-05-22 | 83,959 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion deriv | 2013-05-21 | 2013-05-22 | 8,815,565 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2013-05-21 | 2013-05-22 | 7,085 | — | $0 | 7,085 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion deriv | 2013-05-21 | 2013-05-22 | 18,795 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion deriv | 2013-05-21 | 2013-05-22 | 1,973,439 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-05-22 | 61,910 | $8.00 | $495.3K | 1,435,202 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-05-22 | 593,618 | $8.00 | $4.75M | 1,373,292 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion | 2013-05-21 | 2013-05-22 | 1,730 | — | $0 | 7,424 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion | 2013-05-21 | 2013-05-22 | 181,689 | — | $0 | 779,674 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion | 2013-05-21 | 2013-05-22 | 2,094 | — | $0 | 5,694 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion | 2013-05-21 | 2013-05-22 | 219,863 | — | $0 | 597,985 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion | 2013-05-21 | 2013-05-22 | 3,498 | — | $0 | 3,600 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | C Conversion | 2013-05-21 | 2013-05-22 | 367,315 | — | $0 | 378,122 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-05-22 | 5,653 | $8.00 | $45.2K | 13,077 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-05-22 | 590 | $8.00 | $4.7K | 13,667 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-05-22 | 8,020 | $6.90 | $55.3K | 1,443,222 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-05-22 | 80 | $6.90 | $552 | 13,747 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-20 | 2013-05-22 | 10,500 | $6.78 | $71.2K | 10,807 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-20 | 2013-05-22 | 100 | $6.78 | $678 | 102 | SEC↗ |